Evidence map›Paper›PMID 17601876›Full record

ArticleEukaryotic cell2007

Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone.

Janyce A Sugui, Julian Pardo, Yun C Chang, Kol A Zarember, Glenn Nardone, Eva M Galvez, Arno Müllbacher, John I Gallin, Markus M Simon, Kyung J Kwon-Chung

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 239 citations in OpenAlex.

  1. Trial
  2. Overexpression ofMicrobiology spectrum · 2026
    Article
  3. Article
  4. Multiplex CRISPR/Cas9 editing of gliotoxin biosynthesis genes in Aspergillus fumigatus reduces pathogenicity in broilers.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  5. Oxidoreductase geneMicrobiology spectrum · 2026
    Article
  6. Article
  7. Molecular mechanisms drivingFrontiers in molecular biosciences · 2026
    Review
  8. ULK1 mediated autophagy in airway cells duringFrontiers in microbiology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Progress in Gliotoxin Research.Molecules (Basel, Switzerland) · 2025
    Review
  14. Review
  15. Recent developments inMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  16. Article
  17. Article
  18. The Expanding Mycovirome ofJournal of fungi (Basel, Switzerland) · 2024
    Review
  19. Article
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Janyce A SuguiLaboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.
Julian Pardo
Yun C Chang
Kol A Zarember
Glenn Nardone
Eva M Galvez
Arno Müllbacher
John I Gallin
Markus M Simon
Kyung J Kwon-Chung
Max Planck Institute of Immunobiology and Epigenetics · DEMinistry of Defense · ILAustralian National University · AUNational Institutes of Health · USUniversity of Freiburg · DE

Funding

Clinical Studies Of Abnormal Host DefenseZIAAI000155 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GALLIN, JOHN I · 2009 to 2022
$3.1M
PHAGOCYTIC CELL FUNCTIONZ01AI000155 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI GALLIN, JOHN I · 1985 to 2008
$404k
Intramural NIH HHS
6 · The paper itself

Abstract

Gliotoxin is an immunosuppressive mycotoxin long suspected to be a potential virulence factor of Aspergillus fumigatus. Recent studies using mutants lacking gliotoxin production, however, suggested that the mycotoxin is not important for pathogenesis of A. fumigatus in neutropenic mice resulting from treatment with cyclophosphomide and hydrocortisone. In this study, we report on the pathobiological role of gliotoxin in two different mouse strains, 129/Sv and BALB/c, that were immunosuppressed by hydrocortisone alone to avoid neutropenia. These strains of mice were infected using the isogenic set of a wild type strain (B-5233) and its mutant strain (gliPDelta) and the the glip reconstituted strain (gliP(R)). The gliP gene encodes a nonribosomal peptide synthase that catalyzes the first step in gliotoxin biosynthesis. The gliPDelta strain was significantly less virulent than strain B-5233 or gliP(R) in both mouse models. In vitro assays with culture filtrates (CFs) of B-5233, gliPDelta, and gliP(R) strains showed the following: (i) deletion of gliP abrogated gliotoxin production, as determined by high-performance liquid chromatography analysis; (ii) unlike the CFs from strains B-5233 and gliP(R), gliPDelta CFs failed to induce proapoptotic processes in EL4 thymoma cells, as tested by Bak conformational change, mitochondrial-membrane potential disruption, superoxide production, caspase 3 activation, and phosphatidylserine translocation. Furthermore, superoxide production in human neutrophils was strongly inhibited by CFs from strain B-5233 and the gliP(R) strain, but not the gliPDelta strain. Our study confirms that gliotoxin is an important virulence determinant of A. fumigatus and that the type of immunosuppression regimen used is important to reveal the pathogenic potential of gliotoxin.

Indexed as

AnimalsApoptosisAspergillosisAspergillus fumigatusbcl-2 Homologous Antagonist-Killer ProteinFungal ProteinsGene DeletionGliotoxinHumansHydrocortisoneImmunosuppression TherapyMiceMice, Inbred BALB CNeutrophilsPeptide SynthasesRespiratory Burstbcl-2 Homologous Antagonist-Killer ProteinFungal ProteinsGliotoxinHydrocortisonenon-ribosomal peptide synthasePeptide SynthasesSuperoxidesVirulence Factors

Identifiers

PMID17601876
PMCPMC2043361
OpenAlexW2155241004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.